Publication

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.

Journal Paper/Review - Oct 15, 2012

Units
PubMed
Doi
Contact

Citation
Emanuel R, Dueck A, Geyer H, Kiladjian J, Slot S, Zweegman S, te Boekhorst P, Commandeur S, Schouten H, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl H, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Harrison C, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson P, Barbui T, Barosi G, Vannucchi A, Passamonti F, Andreasson B, Ferrari M, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa R. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol 2012; 30:4098-103.
Type
Journal Paper/Review (English)
Journal
J Clin Oncol 2012; 30
Publication Date
Oct 15, 2012
Issn Electronic
1527-7755
Pages
4098-103
Brief description/objective

Myeloproliferative neoplasm (MPN) symptoms are troublesome to patients, and alleviation of this burden represents a paramount treatment objective in the development of MPN-directed therapies. We aimed to assess the utility of an abbreviated symptom score for the most pertinent and representative MPN symptoms for subsequent serial use in assessing response to therapy.